Unknown

Dataset Information

0

New Insight into Vitamins E and K1 as Anti-Quorum-Sensing Agents against Pseudomonas aeruginosa.


ABSTRACT: Today, antivirulence compounds that attenuate bacterial pathogenicity and have no interference with bacterial viability or growth are introduced as the next generation of antibacterial agents. However, the development of such compounds that can be used by humans is restricted by various factors, including the need for extensive economic investments, the inability of many molecules to penetrate the membrane of Gram-negative bacteria, and unfavorable pharmacological properties and cytotoxicity. Here, we take a new and different look into two frequent supplements, vitamin E and K1, as anti-quorum-sensing agents against Pseudomonas aeruginosa, a pathogen that is hazardous to human life and responsible for several diseases. Both vitamins showed significant anti-biofilm activity (62% and 40.3% reduction by vitamin E and K1, respectively), and the expression of virulence factors, including pyocyanin, pyoverdine, and protease, was significantly inhibited, especially in the presence of vitamin E. Cotreatment of constructed biofilms with these vitamins plus tobramycin significantly reduced the number of bacterial cells sheltered inside the impermeable matrix (71.6% and 69% by a combination of tobramycin and vitamin E or K1, respectively). The in silico studies, besides the similarities of chemical structures, reinforce the possibility that both vitamins act through inhibition of the PqsR protein. This is the first report of the antivirulence and antipathogenic activity of vitamin E and K1 against P. aeruginosa and confirms their potential for further research against other multidrug-resistant bacteria.

SUBMITTER: Soltani S 

PROVIDER: S-EPMC8316004 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

New Insight into Vitamins E and K<sub>1</sub> as Anti-Quorum-Sensing Agents against Pseudomonas aeruginosa.

Soltani Sadaf S   Fazly Bazzaz Bibi Sedigheh BS   Hadizadeh Farzin F   Roodbari Fatemeh F   Soheili Vahid V  

Antimicrobial agents and chemotherapy 20210518 6


Today, antivirulence compounds that attenuate bacterial pathogenicity and have no interference with bacterial viability or growth are introduced as the next generation of antibacterial agents. However, the development of such compounds that can be used by humans is restricted by various factors, including the need for extensive economic investments, the inability of many molecules to penetrate the membrane of Gram-negative bacteria, and unfavorable pharmacological properties and cytotoxicity. He  ...[more]

Similar Datasets

| S-EPMC10557443 | biostudies-literature
| S-EPMC7015896 | biostudies-literature
| S-EPMC7230538 | biostudies-literature
| S-EPMC7569791 | biostudies-literature
| S-EPMC9138634 | biostudies-literature
| S-EPMC3060279 | biostudies-literature
| S-EPMC10221562 | biostudies-literature
| S-EPMC2000394 | biostudies-literature
| S-EPMC7004148 | biostudies-literature
| S-EPMC6456851 | biostudies-literature